The Challenges of Using UK Renal Registry Data to Audit the Care of Patients with Diabetes on Renal Replacement Therapy
- 1 September 2020
- journal article
- research article
- Published by S. Karger AG in Nephron
- Vol. 144 (9), 440-446
- https://doi.org/10.1159/000508637
Abstract
Introduction:Diabetes is a major cause of CKD and of mortality in patients on renal replacement therapy (RRT). Auditing the care of patients with diabetes on RRT against published guidelines relies on robust data collection.Objective:This article assesses the completeness of data items collected by the UK Renal Registry (UKRR) that are required to audit the care of patients with diabetes on RRT.Methods:The UKRR receives data on all patients receiving RRT in the UK. Patients with diabetes, diabetes type, and method of renal diagnosis were identified from primary renal disease (PRD) codes and comorbidity data for patients commencing RRT at one of the 57 renal centres in England and Wales between 2010 and 2016. The completeness of demographic and clinical data (blood pressure, cholesterol, glycated haemoglobin [HbA1c], and smoking status) was assessed for the first year of RRT.Results:Ninety-three per cent of all patients on RRT irrespective of diagnosis had a PRD code, but only 28/57 renal centres had comorbidity data completeness >= 70%; 34.9% of patients with diabetic nephropathy (DN) had type 1 diabetes, but this varied between centres (9.2-100%). Overall, 4.2% of DN diagnoses were by biopsy. Data completeness in the first year of RRT for cardiovascular risk factors ranged between 50.0 and 80.0%, with HbA1c data completeness being 63.0%. Of 57 centres, 20 had HbA1c data for >= 70% of patients in the first year of RRT.Conclusions:There is persistent variation between renal centres in the completeness of data collected on patients with diabetes on RRT, impacting on the ability to undertake robust audit. Data linkages and expanded data permissions could see registry data play a key role in ongoing audit and research into patients with diabetes and CKD, provided adequate data can be collected.This publication has 25 references indexed in Scilit:
- Measurement of Hemoglobin A1cDiabetes Care, 2012
- Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid conditionBMC Nephrology, 2011
- Smoking is a risk factor in the progression to kidney failureKidney International, 2011
- Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal diseaseDiabetes Research and Clinical Practice, 2011
- Renal Association Clinical Practice Guideline on Peritoneal DialysisNephron Clinical Practice, 2011
- Renal Association Clinical Practice Guideline on Cardiovascular Disease in CKDNephron Clinical Practice, 2011
- Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney®ScoresBMC Family Practice, 2010
- Incidences, Treatments, Outcomes, and Sex Effect on Survival in Patients With End-Stage Renal Disease by Diabetes Status in Australia and New Zealand (1991–2005)Diabetes Care, 2007
- Patients with diabetic nephropathy on renal replacement therapy in England and WalesQJM: An International Journal of Medicine, 2007
- Renal Outcome in Type 2 Diabetic Patients With or Without Coexisting Nondiabetic NephropathiesDiabetes Care, 2002